Simplex Trading, LLC Biomea Fusion, Inc. Transaction History

Simplex Trading, LLC

  • $2.81 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 25, 2024
BUY
$13.92 - $19.5 $320,535 - $449,026
23,027 New
23,027 $344,000
Q3 2023

Nov 01, 2023
BUY
$13.44 - $23.02 $80,653 - $138,143
6,001 New
6,001 $82,000
Q1 2023

Apr 27, 2023
BUY
$6.8 - $32.35 $104,033 - $494,922
15,299 New
15,299 $474,000
Q3 2022

Nov 04, 2022
BUY
$9.51 - $13.61 $31,411 - $44,953
3,303 New
3,303 $32,000

Others Institutions Holding BMEA

# of Institutions
104
Shares Held
17.8M
Call Options Held
1.68M
Put Options Held
410K
View Full List

About Biomea Fusion, Inc.

BMEA Quotes by TradingView
  • Ticker BMEA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,290,600
  • Market Cap $189M
  • Description
  • Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...
More about BMEA
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email